PCSK9 inhibition for autosomal recessive hypercholesterolemia

Atherosclerosis. 2019 May:284:209-211. doi: 10.1016/j.atherosclerosis.2019.02.013. Epub 2019 Feb 23.

Authors

Kévin Chemello¹, Cesar Martín², Gilles Lambert³

Affiliations

¹ Laboratoire Inserm UMR 1188 DéTROI, Université de la Réunion, Sainte-Clotilde, France.
² Biofisika Institute (UPV/EHU, CSIC) and Departamento de Bioquímica, Universidad del País Vasco, Bilbao, Spain.
³ Laboratoire Inserm UMR 1188 DéTROI, Université de la Réunion, Sainte-Clotilde, France. Electronic address: gilles.lambert@univ-reunion.fr.

PMID: 30862376
DOI: 10.1016/j.atherosclerosis.2019.02.013

No abstract available

Keywords: Familial hypecholesterolemia; LDL-cholesterol; PCSK9.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Adaptor Proteins, Signal Transducing
Anticholesteremic Agents*
Humans
Hypercholesterolemia*
Proprotein Convertase 9
Proprotein Convertases

Substances

Adaptor Proteins, Signal Transducing
Anticholesteremic Agents
LDLRAP1 protein, human
PCSK9 protein, human
Proprotein Convertase 9
Proprotein Convertases